And the Nobel prize for vision award goes to?

Article

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

The $1.3 million award, the largest of its kind in ophthalmology will be shared between J Anthony Movshon, director of New York University’s Centre for Neural Science and William T. Newsome, a neuroscientist at Stanford University.

For over three decades both scientists have worked jointly and separately on the way our brains process visual information, supporting our perception. Leonor Beleza, president of The Champalimaud Foundation, said: “Visual perception starts with the eyes, but it happens in the brain. Over a 30-year period, the work of Movshon and Newsome has taken this axiom to new scientific levels of understanding. Because of these two outstanding neuroscientists, we now have a fundamental appreciation for the role of neurons in how we see things move about in the world. Their ground-breaking work, taken together and individually, has laid the basis for continued research on how the brain and its processes impact vision and perception. We are very proud to recognize Movshon and Newsome as the recipients of the 2010 Champalimaud Vision Award.”

According to www.healthnewsdigest.com William Newsome heard about the award following a weekly lab meeting when he listened to his mobile phone messages: “There was a message from my wife telling me an ophthalmologist in Portugal had called and told her he was absolutely sure I would really, really want to call him back.” The ophthalmologist turned out to be a member of the Champalimaud jury panel: Alfred Summer, MD, dean of the School of Hygiene and Public Health and professor of ophthalmology, epidemiology and international health at Johns Hopkins University.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.